F Berezin - Concepedia

Author

F Berezin

Also Known As

F Berezin, F K Berezin, F. Berezin, Frances Berezin

Publications

385

Citations

H-Index

Concepts

All Affiliations

F Berezin is an author at University of Chicago specializing in pharmacotherapy, drug discovery, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	244
2	Pharmacology	4	4	244
3	Allergy	1	1	64
4	Biochemistry	1	1	61
5	Medical Laboratory Science	1	1	109

F Berezin

Publications

368

Citations

H-Index

Page 1

	Year	Citations
Pharmacologically based dosing of etoposide: a means of safely increasing dose intensity. Mark J. Ratain, Rosemarie Mick, Richard L. Schilsky, Journal of Clinical Oncology Bone Marrow FunctionDose IntensityPharmacotherapyExperimental PharmacologyMolecular Pharmacology	1991	109
Paradoxical relationship between acetylator phenotype and amonafide toxicity Mark J. Ratain, Rosemarie Mick, F Berezin, Clinical Pharmacology & Therapeutics	1991	81
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent. E Gupta, Olufunmilayo I. Olopade, Mark J. Ratain, PubMed Chemopreventive AgentAllergyPharmacological StudyDrug DiscoveryOltipraz Cmax	1995	64
Phase I study of amonafide dosing based on acetylator phenotype. Mark J. Ratain, Rosemarie Mick, F Berezin, PubMed Phenotype CategoryMolecular PharmacologyOncologyChemoprevention StrategyBiochemistry	1993	61
Individualized dosing of amonafide based on a pharmacodynamic model incorporating acetylator phenotype and gender Mark J. Ratain, Rosemarie Mick, Linda Janisch, Pharmacogenetics	1996	43
Phase I and pharmacokinetic study of a new antineoplastic agent: pyrazine diazohydroxide (NSC 361456). Nicholas J. Vogelzang, Rosemarie Mick, Linda Janisch, PubMed Pharmaceutical SciencePharmacotherapyAdvanced Cancer RefractoryMetronomic ChemotherapyPharmaceutical Chemistry	1994	10

Page 1